ZA200303276B - Stable pharmaceutical form of an anticancer drug and method for production of stable pharmaceutical form of an anticancer drug. - Google Patents

Stable pharmaceutical form of an anticancer drug and method for production of stable pharmaceutical form of an anticancer drug.

Info

Publication number
ZA200303276B
ZA200303276B ZA200303276A ZA200303276A ZA200303276B ZA 200303276 B ZA200303276 B ZA 200303276B ZA 200303276 A ZA200303276 A ZA 200303276A ZA 200303276 A ZA200303276 A ZA 200303276A ZA 200303276 B ZA200303276 B ZA 200303276B
Authority
ZA
South Africa
Prior art keywords
anticancer drug
pharmaceutical form
stable pharmaceutical
production
stable
Prior art date
Application number
ZA200303276A
Other languages
English (en)
Inventor
Stanislaw Janicki
Malgorzata Sznitowska
Wladyslaw Karas
Zdzislaw Mroczek
Andrzej Tyrala
Iwona Czarnecka
Original Assignee
Warszawskie Zaklady Farma
Akad Medyczna
Inst Chemii Organicznej Pan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warszawskie Zaklady Farma, Akad Medyczna, Inst Chemii Organicznej Pan filed Critical Warszawskie Zaklady Farma
Publication of ZA200303276B publication Critical patent/ZA200303276B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA200303276A 2000-10-31 2003-04-29 Stable pharmaceutical form of an anticancer drug and method for production of stable pharmaceutical form of an anticancer drug. ZA200303276B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL343615A PL203300B1 (pl) 2000-10-31 2000-10-31 Stabilna postać farmaceutyczna leku przeciwnowotworowego oraz sposób wytwarzania stabilnej postaci farmaceutycznej leku przeciwnowotworowego

Publications (1)

Publication Number Publication Date
ZA200303276B true ZA200303276B (en) 2004-04-21

Family

ID=20077651

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200303276A ZA200303276B (en) 2000-10-31 2003-04-29 Stable pharmaceutical form of an anticancer drug and method for production of stable pharmaceutical form of an anticancer drug.

Country Status (14)

Country Link
EP (1) EP1363892B1 (cs)
AU (1) AU2002212863A1 (cs)
BG (1) BG65985B1 (cs)
CZ (1) CZ300836B6 (cs)
DE (1) DE60122384T2 (cs)
HU (1) HUP0303089A3 (cs)
LT (1) LT5069B (cs)
PL (1) PL203300B1 (cs)
RU (1) RU2236227C1 (cs)
SI (1) SI21138B (cs)
SK (1) SK287850B6 (cs)
UA (1) UA75620C2 (cs)
WO (1) WO2002036582A1 (cs)
ZA (1) ZA200303276B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04005038A (es) * 2001-11-30 2004-08-11 Bristol Myers Squibb Co Solvatos de paclitaxel.
DK1694660T3 (da) 2003-12-12 2009-08-10 Biorganica Ltda Fremgangsmåde til fremstilling af vandfri og hydrerede aktive farmaceutiske bestanddele (API's); stabile farmaceutiske sammensætninger fremstillet af disse og anvendelser af disse sammensætninger
AR054215A1 (es) * 2006-01-20 2007-06-13 Eriochem Sa Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kit
EP2146695A4 (en) * 2007-04-23 2010-05-19 Sun Pharmaceuticals Ind Ltd PHARMACEUTICAL COMPOSITIONS
RU2370258C2 (ru) * 2007-11-16 2009-10-20 Закрытое Акционерное Общество "Биокад" Фармацевтическая композиция для парентеральной доставки в форме лиофилизата и способ ее получения
CN110437179A (zh) * 2019-08-22 2019-11-12 江苏红豆杉药业有限公司 一种紫杉醇单晶晶体及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678833B1 (fr) * 1991-07-08 1995-04-07 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques a base de derives de la classe des taxanes.
RU2136673C1 (ru) * 1992-12-24 1999-09-10 Бристоль-Мейерз Сквибб Компани Фосфонооксиметиловые эфиры таксановых производных, промежуточные соединения, противоопухолевая фармацевтическая композиция, способ ингибирования роста опухоли у млекопитающих
TW406020B (en) * 1993-09-29 2000-09-21 Bristol Myers Squibb Co Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent
CA2163837C (en) * 1994-12-13 1999-07-20 Robert K. Perrone Crystalline paclitaxel hydrates
FR2729666A1 (fr) * 1995-01-25 1996-07-26 Rhone Poulenc Rorer Sa Procede de preparation du trihydrate du (2r, 3s)- benzoylamino-2-hydroxy-3-phenylpropionate de 4,10-diacetoxy- 2alpha-benzoyloxy-5beta,20-epoxy-1,7beta-dihydroxy-9-oxo- tax-11-en-13alpha-yle
FR2740686B1 (fr) * 1995-11-03 1998-01-16 Sanofi Sa Formulation pharmaceutique lyophilisee stable

Also Published As

Publication number Publication date
DE60122384D1 (de) 2006-09-28
AU2002212863A1 (en) 2002-05-15
HK1060733A1 (en) 2004-08-20
DE60122384T2 (de) 2007-08-16
WO2002036582A1 (en) 2002-05-10
LT2003031A (en) 2003-09-25
SI21138B (sl) 2006-10-31
SI21138A (sl) 2003-08-31
LT5069B (lt) 2003-11-25
CZ20031421A3 (cs) 2004-06-16
HUP0303089A3 (en) 2005-02-28
SK287850B6 (sk) 2012-01-04
BG65985B1 (bg) 2010-08-31
EP1363892B1 (en) 2006-08-16
UA75620C2 (en) 2006-05-15
RU2236227C1 (ru) 2004-09-20
HUP0303089A2 (hu) 2003-12-29
EP1363892A1 (en) 2003-11-26
BG107764A (bg) 2004-07-30
CZ300836B6 (cs) 2009-08-19
PL203300B1 (pl) 2009-09-30
SK6292003A3 (en) 2004-08-03
PL343615A1 (en) 2002-05-06

Similar Documents

Publication Publication Date Title
MXPA02003596A (es) Composiciones farmaceuticas novedosas de farmacos anti tubercular y procedimiento para su preparacion.
AU2682401A (en) Flavonoid drug and dosage form, its production and use
HUP0201711A3 (en) N-indanyl-benzamide derivatives, method for their production, their use and pharmaceutical preparations containing them
HUP0105478A3 (en) 16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use
HUP0204372A3 (en) Pharmaceutical compositions providing enhanced drug concentrations
IL160797A0 (en) ORAL PHARMACEUTICAL PRODUCTS CONTAINING 17beta-ESTRADIOL-3-LOWER ALKANOATE, METHOD OF ADMINISTERING THE SAME AND PROCESS OF PREPARATION
HUP0000748A2 (en) 4-phenyl-piridine derivatives, process for producing them and pharmaceutical compositions containing them
HUP0302257A3 (en) 4-hydrazino-5-hydroxy-5-pyrazol derivatives, pharmaceutical compositions containing them, process for producing them and their intermediates
AU6271401A (en) Drug administering system and administering method
IL154012A0 (en) Hydrogel-driven drug dosage form
HUP0302050A3 (en) Pharmaceutical form of administration for peptides, method for its production and use
WO2001010816A3 (de) Substituierte 2-Dialkylaminoalkylbiphenyl-derivate
AU2001278849A1 (en) Method of increased bioavailability of nutrients and pharmaceutical preparationswith tetrahydropiperine and its analogues and derivatives
GB0017060D0 (en) Production, stabilisation and use of reduced forms of pharmaceutical compounds
SG116507A1 (en) Pharmaceutical dosage form and method of making.
HUP0203496A3 (en) Novel cyclopropane derivatives, pharmaceutical compositions containing them and method for the production thereof
MXPA03009391A (es) METODO PARA FABRICAR UNA COMPOSICIoN FARMACEUTICA DE DOSIS BAJA.
AU2001238346A1 (en) Modification of biopolymers for improved drug delivery
HUP0400926A3 (en) Lipid lowering new biphenylcarboxamides, process for their preparation and pharmaceutical compositions containing them
NO20026212L (no) Forbindelse for medikamentavleveringssystem og fremgangsmåte for fremstilling av forbindelsen
AU3156600A (en) Novel epothilon derivatives, method for the production thereof and their pharmaceutical application
HUP0400549A3 (en) Novel imidazole derivatives, production method thereof and pharmaceutical compositions containing them
AU2001250646A1 (en) Drug delivery system for avoiding pharmacokinetic interaction between drugs and method thereof
AP2003002927A0 (en) Pharmaceutical formulation having a masked taste and method for the production thereof.
HUP0105479A3 (en) Betha-alanine derivatives, process for producing them and pharmaceutical compositions containing them